Small‐Molecule Modulators for Epigenetics Targets

descriptionPublicationkeyboard_double_arrow_right Article 14 Oct 2013 United Kingdom English Publisher:WileyJournal:ChemMedChem, volume 8, pages 1,885-1,891 (issn: 1860-7179, eissn: 1860-7187,

Copyright policy )

Authors: Knapp, S; Weinmann, H;

doi: 10.1002/cmdc.201300344

pmid: 24127276

Small‐Molecule Modulators for Epigenetics Targets

- Summary
- Subjects
- Metrics

Abstract

A capital conference: Influencing epigenetic mechanisms may be highly relevant for future therapies of various diseases such as cancer, inflammation, and metabolic disorders. Leading experts in the field gathered in Berlin on June 5-6, 2013 at a Bayer HealthCare Life Science Workshop to share recent success stories and to discuss future trends.

Country

United Kingdom

Related Organizations

University of Oxford
United Kingdom
Bayer Corporation
United States
Bayer (Germany)
Germany

Keywords

Small Molecule Libraries, Drug Delivery Systems, Molecular Structure, Histone Methyltransferases, Humans, Histone-Lysine N-Methyltransferase, Epigenesis, Genetic

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	20
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%